Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ramachandran, Kaliaperumal"'
Publikováno v:
Journal of Laboratory Physicians, Vol 12, Iss 03, Pp 191-195 (2020)
Introduction With increasing automation in clinical laboratories, the requirements for quality control (QC) material have greatly increased in order to monitor performance. The constant use of commercial control material is not economically feasible
Externí odkaz:
https://doaj.org/article/5b7eee111790480b8775b2c3fa8a71c8
Autor:
Rathnakumar Krishnamoorthy, Ramachandran Kaliaperumal, Ramesh Venkatachalam, R Poovitha, Geetha Rajagopalan
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 11, Iss 10, Pp NC01-NC05 (2017)
Introduction: Diabetic Retinopathy (DR) is one of the most common microvascular complications of diabetes and is the leading cause of blindness and visual impairment worldwide. Dyslipidemia is the major biochemical alteration in diabetes mellitus. So
Externí odkaz:
https://doaj.org/article/fdb06cc683e0413daf51560e1c4f1976
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 8, Iss 2, Pp 37-39 (2014)
Background and Objective: Changes in plasma lipid concentrations are well known metabolic consequences of thyroid dysfunction. The alterations are most prominent in hypothyroidism which is typically associated with pronounced hypercholesterolaemia
Externí odkaz:
https://doaj.org/article/6259e21e356c41eaae81e1b00f4a9ff6
Autor:
Ramesh Venkatachalam, Anitha Devaraj, Buvana Balamugundan, Anebaracy, Rathna Kumar, Poovitha R, Ramachandran Kaliaperumal, Geetha Rajagopalan
Publikováno v:
Asian Journal of Pharmaceutical and Clinical Research. 10:112
Objectives: Diabetic retinopathy (DR) is one of the microvascular complications in type 2 diabetes (T2D). Elevated serum uric acid (SUA) has been shown to play a significant role in diabetic neuropathy and nephropathy but there is little information
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 8, Iss 2, Pp 37-39 (2014)
Background and Objective: Changes in plasma lipid concentrations are well known metabolic consequences of thyroid dysfunction. The alterations are most prominent in hypothyroidism which is typically associated with pronounced hypercholesterolaemia an
Autor:
Rathnakumar, Krishnamoorthy, Ramachandran, Kaliaperumal, Baba, Durairaj, Ramesh, Venkatachalam, Anebaracy, Velusamy, Vidhya, Ramachandran, Vinothkumar, Rajamanickam, Poovitha, Ramamurthy, Geetha, Rajagopalan
Publikováno v:
Journal of Basic & Clinical Physiology & Pharmacology; Mar2018, Vol. 29 Issue 2, p195-199, 5p